PCVX
Price
$30.79
Change
+$0.02 (+0.06%)
Updated
Aug 29 closing price
Capitalization
4B
72 days until earnings call
STOK
Price
$19.76
Change
-$0.01 (-0.05%)
Updated
Aug 29 closing price
Capitalization
1.08B
73 days until earnings call
Interact to see
Advertisement

PCVX vs STOK

Header iconPCVX vs STOK Comparison
Open Charts PCVX vs STOKBanner chart's image
Vaxcyte
Price$30.79
Change+$0.02 (+0.06%)
Volume$944.9K
Capitalization4B
Stoke Therapeutics
Price$19.76
Change-$0.01 (-0.05%)
Volume$623.55K
Capitalization1.08B
PCVX vs STOK Comparison Chart in %
Loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCVX vs. STOK commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a Hold and STOK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (PCVX: $30.79 vs. STOK: $19.76)
Brand notoriety: PCVX and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 67% vs. STOK: 76%
Market capitalization -- PCVX: $4B vs. STOK: $1.08B
PCVX [@Biotechnology] is valued at $4B. STOK’s [@Biotechnology] market capitalization is $1.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 1 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than PCVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 5 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • PCVX’s TA Score: 5 bullish, 5 bearish.
  • STOK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both PCVX and STOK are a good buy in the short-term.

Price Growth

PCVX (@Biotechnology) experienced а -4.65% price change this week, while STOK (@Biotechnology) price change was +1.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

PCVX is expected to report earnings on Nov 10, 2025.

STOK is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4B) has a higher market cap than STOK($1.08B). STOK YTD gains are higher at: 79.148 vs. PCVX (-62.387). STOK has higher annual earnings (EBITDA): 42.3M vs. PCVX (-584.35M). PCVX has more cash in the bank: 1.66B vs. STOK (248M). STOK has less debt than PCVX: STOK (2.3M) vs PCVX (85.8M). STOK has higher revenues than PCVX: STOK (200M) vs PCVX (0).
PCVXSTOKPCVX / STOK
Capitalization4B1.08B369%
EBITDA-584.35M42.3M-1,381%
Gain YTD-62.38779.148-79%
P/E RatioN/A22.72-
Revenue0200M-
Total Cash1.66B248M670%
Total Debt85.8M2.3M3,737%
FUNDAMENTALS RATINGS
STOK: Fundamental Ratings
STOK
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
45
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PCVXSTOK
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMRRX34.92N/A
N/A
BlackRock Mid-Cap Growth Equity R
HDPMX83.30N/A
N/A
Hodges Retail
RYMGX51.51N/A
N/A
Rydex S&P MidCap 400 Pure Growth A
QRLVX34.71N/A
N/A
Federated Hermes MDT Large Cap Value R
AMONX24.23-0.19
-0.78%
AQR Large Cap Momentum Style N